| Date Filed | Type | Description |
| 03/16/2022 |
4
| Giordano Natasha (CEO) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Bought 4,100 shares
@ $3.6529, valued at
$15k
|
|
| 03/16/2022 |
4
| O'Connor Rita M (CFO) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Bought 10,000 shares
@ $3.66, valued at
$36.6k
Bought 3,700 shares
@ $3.6546, valued at
$13.5k
|
|
| 02/24/2022 |
4
| Valentino Michael J (Executive Chairman) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 80,000 options to buy
@ $4.99, valued at
$399.2k
|
|
| 02/24/2022 |
4
| O'Connor Rita M (CFO) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 110,000 options to buy
@ $4.99, valued at
$548.9k
|
|
| 02/24/2022 |
4
| HADDEN JOHN (Director) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 20,000 options to buy
@ $4.99, valued at
$99.8k
|
|
| 02/24/2022 |
4
| Giordano Natasha (CEO) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 300,000 options to buy
@ $4.99, valued at
$1.5M
|
|
| 02/24/2022 |
4
| Casale Robert (Director) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 20,000 options to buy
@ $4.99, valued at
$99.8k
|
|
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2021 |
4
| O'Connor Rita M (CFO) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 100,000 options to buy
@ $16.97, valued at
$1.7M
|
|
| 08/11/2021 |
4
| Giordano Natasha (CEO) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 200,000 options to buy
@ $16.97, valued at
$3.4M
|
|
| 06/15/2021 |
4
| Valentino Michael J (Executive Chairman) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Bought 1,200 shares
@ $12.44, valued at
$14.9k
Bought 400 shares
@ $12.445, valued at
$5k
Bought 100 shares
@ $12.45, valued at
$1.2k
Bought 100 shares
@ $12.465, valued at
$1.2k
Bought 600 shares
@ $12.47, valued at
$7.5k
Bought 300 shares
@ $12.4725, valued at
$3.7k
Bought 100 shares
@ $12.485, valued at
$1.2k
Bought 5,080 shares
@ $12.5, valued at
$63.5k
Bought 120 shares
@ $12.505, valued at
$1.5k
|
|
| 03/16/2021 |
3
| Level One Partners, LLC (10% Owner) has filed a Form 3 on PLx Pharma Inc. |
| 03/09/2021 |
4
| Valentino Michael J (Executive Chairman) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Bought 25,000 shares
@ $8, valued at
$200k
|
|
| 12/15/2020 |
4
| HADDEN JOHN (Director) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Bought 600 shares
@ $5.42, valued at
$3.3k
Bought 400 shares
@ $5.4899, valued at
$2.2k
|
|
| 11/25/2020 |
4
| HADDEN JOHN (Director) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Bought 500 shares
@ $5.4757, valued at
$2.7k
|
|
| 11/20/2020 |
4
| Valentino Michael J (Executive Chairman) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Bought 264,900 shares
@ $3.787, valued at
$1M
Granted 160,000 options to buy
@ $5.15, valued at
$824k
Bought 291,390 warrants
@ $4.31, valued at
$1.3M
|
|
| 11/20/2020 |
4
| O'Connor Rita M (CFO) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 174,000 options to buy
@ $5.15, valued at
$896.1k
|
|
| 11/20/2020 |
4
| HADDEN JOHN (Director) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 40,000 options to buy
@ $5.15, valued at
$206k
|
|
| 11/20/2020 |
4
| Giordano Natasha (CEO) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 350,000 options to buy
@ $5.15, valued at
$1.8M
|
|
| 11/20/2020 |
4
| Casale Robert (Director) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 40,000 options to buy
@ $5.15, valued at
$206k
|
|
| 11/20/2020 |
4
| CALHOUN KIRK K (Director) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 40,000 options to buy
@ $5.15, valued at
$206k
|
|
| 11/20/2020 |
4
| Balkema Gary S. (Director) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 40,000 options to buy
@ $5.15, valued at
$206k
|
|
| 09/03/2020 |
4
| O'Connor Rita M (CFO) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Bought 4,500 shares
@ $3.7416, valued at
$16.8k
Bought 2,120 shares
@ $3.8333, valued at
$8.1k
|
|
| 08/24/2020 |
4
| O'Connor Rita M (CFO) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Bought 2,300 shares
@ $3.7677, valued at
$8.7k
Bought 4,050 shares
@ $3.973, valued at
$16.1k
|
|
| 05/19/2020 |
4
| Park West Asset Management LLC (10% Owner) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Bought 6,000 convertible preferred
@ $1000, valued at
$6M
|
|
| 03/24/2020 |
4
| Valentino Michael J (Executive Chairman) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 80,000 options to buy
@ $2.16, valued at
$172.8k
|
|
| 03/24/2020 |
4
| O'Connor Rita M (CFO) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 87,000 options to buy
@ $2.16, valued at
$187.9k
|
|
| 03/24/2020 |
4
| HADDEN JOHN (Director) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.16, valued at
$43.2k
|
|
| 03/24/2020 |
4
| Giordano Natasha (CEO) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 175,000 options to buy
@ $2.16, valued at
$378k
|
|
| 03/24/2020 |
4
| Deliargyris Efthymios (Chief Medical Officer) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 60,000 options to buy
@ $2.16, valued at
$129.6k
|
|
| 03/24/2020 |
4
| Casale Robert (Director) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.16, valued at
$43.2k
|
|
| 03/24/2020 |
4
| CALHOUN KIRK K (Director) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.16, valued at
$43.2k
|
|
| 03/24/2020 |
4
| Balkema Gary S. (Director) has filed a Form 4 on PLx Pharma Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.16, valued at
$43.2k
|
|
|